Arjo AB (publ) (ARJO_B) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Arjo Q1 Presentation for 2026. Now I will hand the conference over to President and CEO, Andreas Eldgaard and CFO, Christopher Carlson. Please go ahead. Thanks a lot and thanks everybody for dialing in and listening to Arjo's first quarter of twenty twenty six. So we believe we have been able to pull together a stable first quarter and we're happy to share that with you and also we will talk a little bit on how we are progressing the work with shaping the future Arjo. So just to begin a little bit from my side and to remind everybody of who we are and what we do because we are really very purpose led in everything we do. This is something that is very strong in Arjo. We exist and are present at people's most vulnerable moments and we help them to keep their integrity and dignity and really make sure that they have the best possible situation when they need it the most. As you know, we work across several product segments and categories, so from patient handling and hygiene to medical beds, the mattresses that goes on top often focused on helping to relieve pressure injuries. We work with VT prevention, diagnostics and disinfection. So these are our product categories. We are about 7,000 people and with an annual turnover of approximately 11,000,000,000 and we are truly a global company with sales to more than 100 countries. So let me just start by a flyover summary of the first quarter of twenty twenty six. So we delivered solid growth in Q1, 3.8% is within our guidance and it's really driven this year by positive trend in U. S. In capital sales and strong sales in rest of the world. And also this year, as you saw in Q4, the flu season was not as strong as it usually is for us in U. S. And that has continued. So this is despite somewhat weak flu season...